Brainstorm Cell Therapeutics falls on tanking cash reserves

Brainstorm Cell Therapeutics

30/03/2023 18:56

** Shares of biotechnology co Brainstorm Cell Therapeutics
Inc  BCLI.O  down 4.2% at $2.33
    ** BCLI reported cash, cash-equivalents and short-term bank
deposits of $3 mln as of year-ended 2022, a steep fall from $22
mln as of year-ended 2021
    ** Net loss for 2022 was about $24.3 mln, or 66 cents per
share, vs net loss of $24.5 mln, or 68 cents per share, in 2021
    ** Shares up ~43% YTD

 (Reporting by Yamini Kalia)
 ((Yamini.Kalia@thomsonreuters.com))